Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$ 971,700	$ 1,066,900
Restricted cash	68,000	16,300
Accounts receivable, less allowances of $10,900 and $11,600, respectively	443,300	479,600
Inventories	379,900	356,200
Short-term deferred tax assets	62,900	78,200
Other current assets	105,300	93,200
Total current assets	2,031,100	2,090,400
Property, plant and equipment, at cost	745,500	667,500
Less accumulated depreciation and amortization	315,200	276,300
Net property, plant and equipment	430,300	391,200
Goodwill	1,097,700	1,099,500
Core and developed technologies, net	638,600	696,800
Other intangible assets, net	447,200	468,100
Deferred tax assets	10,900	3,900
Other assets	457,900	291,200
Total assets	5,113,700	5,041,100
Current liabilities
Accounts payable	81,300	83,000
Accrued expenses	402,600	294,000
Accrued compensation and benefits	136,700	145,300
Income taxes payable	24,300	64,200
Total current liabilities	644,900	586,500
Long-term debt	1,402,800	1,405,700
Other long-term liabilities	1,107,700	798,800
Deferred income taxes	126,100	161,900
Commitments and contingencies
Shareholders' investment:
Preferred stock, $1 par value, authorized 5,000,000 shares; none issued
Common stock, $0.25 par value, authorized 600,000,000 shares; issued and outstanding 74,898,741 shares at September 30, 2014 and 77,436,263 shares at December 31, 2013	18,700	19,400
Capital in excess of par value	1,880,400	1,729,600
Accumulated deficit / retained earnings	(37,600)	360,100
Accumulated other comprehensive loss	(29,300)	(20,900)
Total shareholders' investment	1,832,200	2,088,200
Total liabilities and shareholders' investment	$ 5,113,700	$ 5,041,100